182 related articles for article (PubMed ID: 25913916)
1. The effect of age and sex on cost of inpatient facility encounters among patients with multiple sclerosis.
Kozma CM; Meletiche DM; Phillips AL
J Med Econ; 2015; 18(9):704-10. PubMed ID: 25913916
[TBL] [Abstract][Full Text] [Related]
2. Descriptive analysis of the direct medical costs of multiple sclerosis in 2004 using administrative claims in a large nationwide database.
Prescott JD; Factor S; Pill M; Levi GW
J Manag Care Pharm; 2007; 13(1):44-52. PubMed ID: 17269836
[TBL] [Abstract][Full Text] [Related]
3. Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the US.
Ivanova JI; Bergman RE; Birnbaum HG; Phillips AL; Stewart M; Meletiche DM
J Med Econ; 2012; 15(3):601-9. PubMed ID: 22376190
[TBL] [Abstract][Full Text] [Related]
4. Cost of care for new versus recurrent acute coronary syndrome patients.
Shetty S; Halpern R; McCollam PL
J Med Econ; 2008; 11(1):81-99. PubMed ID: 19450112
[TBL] [Abstract][Full Text] [Related]
5. Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis.
Yermakov S; Davis M; Calnan M; Fay M; Cox-Buckley B; Sarda S; Duh MS; Iyer R
J Med Econ; 2015; 18(9):711-20. PubMed ID: 25903661
[TBL] [Abstract][Full Text] [Related]
6. Costs and quality of life of multiple sclerosis in Switzerland.
Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338
[TBL] [Abstract][Full Text] [Related]
7. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H
J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric inpatient expenditures and public health insurance programmes: analysis of a national database covering the entire South Korean population.
Chung W
BMC Health Serv Res; 2010 Sep; 10():263. PubMed ID: 20819235
[TBL] [Abstract][Full Text] [Related]
9. Costs and quality of life of multiple sclerosis in Sweden.
Berg J; Lindgren P; Fredrikson S; Kobelt G
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342
[TBL] [Abstract][Full Text] [Related]
10. Costs and quality of life of multiple sclerosis in the United Kingdom.
Kobelt G; Berg J; Lindgren P; Kerrigan J; Russell N; Nixon R
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S96-104. PubMed ID: 17310341
[TBL] [Abstract][Full Text] [Related]
11. Costs and quality of life of multiple sclerosis in Austria.
Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339
[TBL] [Abstract][Full Text] [Related]
12. Discharge dispositions, complications, and costs of hospitalization in spinal cord tumor surgery: analysis of data from the United States Nationwide Inpatient Sample, 2003-2010.
Sharma M; Sonig A; Ambekar S; Nanda A
J Neurosurg Spine; 2014 Feb; 20(2):125-41. PubMed ID: 24286530
[TBL] [Abstract][Full Text] [Related]
13. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
14. Resource utilization for observation-status stays at children's hospitals.
Fieldston ES; Shah SS; Hall M; Hain PD; Alpern ER; Del Beccaro MA; Harding J; Macy ML
Pediatrics; 2013 Jun; 131(6):1050-8. PubMed ID: 23669520
[TBL] [Abstract][Full Text] [Related]
15. Direct and indirect cost burden associated with multiple sclerosis relapses: excess costs of persons with MS and their spouse caregivers.
Parisé H; Laliberté F; Lefebvre P; Duh MS; Kim E; Agashivala N; Abouzaid S; Weinstock-Guttman B
J Neurol Sci; 2013 Jul; 330(1-2):71-7. PubMed ID: 23647840
[TBL] [Abstract][Full Text] [Related]
16. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
Asche CV; Joish VN; Camacho F; Drake CL
Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
[TBL] [Abstract][Full Text] [Related]
17. Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from Turkey.
Karabudak R; Karampampa K; Calışkan Z;
J Med Econ; 2015 Jan; 18(1):69-75. PubMed ID: 25116693
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis: relapses, resource use, and costs.
Hawton AJ; Green C
Eur J Health Econ; 2016 Sep; 17(7):875-84. PubMed ID: 26438399
[TBL] [Abstract][Full Text] [Related]
19. Costs and quality of life of multiple sclerosis in Germany.
Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337
[TBL] [Abstract][Full Text] [Related]
20. Inpatient burden of constipation in the United States: an analysis of national trends in the United States from 1997 to 2010.
Sethi S; Mikami S; Leclair J; Park R; Jones M; Wadhwa V; Sethi N; Cheng V; Friedlander E; Bollom A; Lembo A
Am J Gastroenterol; 2014 Feb; 109(2):250-6. PubMed ID: 24419480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
